Posted in | News

AREVA and MItsubishi Corp Partner in Australian Uranium Exploration

AREVA and Mitsubishi Corporation, through their respective subsidiaries Afmeco Mining and Exploration Pty Ltd (AFMEX) and Mitsubishi Development Pty Ltd (MDP), have decided to work together in a uranium exploration program in Australia.

Exploration will be conducted for several years across tens of thousands of square kilometers of Australia where little or no previous exploration has yet been undertaken.

Under the terms of the agreement entered into between both companies, MDP will cover 100% of AFMEX's exploration expenditure for several years up to a predetermined amount. Once the threshold is reached and if MDP confirms its interest, MDP will have the option to acquire 49% of the greenfield* uranium exploration permits held by AFMEX in Australia and enter into a joint venture owned 51% by AFMEX and 49% by MDP. The operations of the new joint venture will be managed by AFMEX.

Olivier Wantz, AREVA Senior Executive Vice President in charge of mining activities stated: "By joining forces through this partnership, AREVA and Mitsubishi Corporation are gaining the means to develop Australia's very substantial uranium potential. We believe that exploitable low production cost deposits will be discovered there over the long term, hence our mutual commitment to financing such a large-scale exploration effort."

Australia produced nearly 6,200 tons (about 16.1 million pounds) of uranium in 2011. It is the world's number three uranium producer behind Kazakhstan and Canada, and its uranium reserves are among the largest in the world. AREVA recently stepped up its exploration efforts in Australia, where it has discovered several deposits since commencing exploration activities there in the 1970s.

(*) Areas where no uranium resources have been identified.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.